These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 24140114)

  • 1. Germline mutations in NFKB2 implicate the noncanonical NF-κB pathway in the pathogenesis of common variable immunodeficiency.
    Chen K; Coonrod EM; Kumánovics A; Franks ZF; Durtschi JD; Margraf RL; Wu W; Heikal NM; Augustine NH; Ridge PG; Hill HR; Jorde LB; Weyrich AS; Zimmerman GA; Gundlapalli AV; Bohnsack JF; Voelkerding KV
    Am J Hum Genet; 2013 Nov; 93(5):812-24. PubMed ID: 24140114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and Immunological Phenotype of Patients With Primary Immunodeficiency Due to Damaging Mutations in
    Klemann C; Camacho-Ordonez N; Yang L; Eskandarian Z; Rojas-Restrepo JL; Frede N; Bulashevska A; Heeg M; Al-Ddafari MS; Premm J; Seidl M; Ammann S; Sherkat R; Radhakrishnan N; Warnatz K; Unger S; Kobbe R; Hüfner A; Leahy TR; Ip W; Burns SO; Fliegauf M; Grimbacher B
    Front Immunol; 2019; 10():297. PubMed ID: 30941118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Case Report of Hypoglycemia and Hypogammaglobulinemia: DAVID Syndrome in a Patient With a Novel NFKB2 Mutation.
    Lal RA; Bachrach LK; Hoffman AR; Inlora J; Rego S; Snyder MP; Lewis DB
    J Clin Endocrinol Metab; 2017 Jul; 102(7):2127-2130. PubMed ID: 28472507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Nonsense N -Terminus NFKB2 Mutation Leading to Haploinsufficiency in a Patient with a Predominantly Antibody Deficiency.
    Kuehn HS; Bernasconi A; Niemela JE; Almejun MB; Gallego WAF; Goel S; Stoddard JL; Sánchez RGP; Franco CAA; Oleastro M; Grunebaum E; Ballas Z; Cunningham-Rundles C; Fleisher TA; Franco JL; Danielian S; Rosenzweig SD
    J Clin Immunol; 2020 Nov; 40(8):1093-1101. PubMed ID: 32813180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenic NFKB2 variant in the ankyrin repeat domain (R635X) causes a variable antibody deficiency.
    Tuijnenburg P; Lango Allen H; de Bree GJ; Savic S; Jansen MH; Stockdale C; Simeoni I; Ten Berge IJM; van Leeuwen EMM; ; Thaventhiran JE; Kuijpers TW
    Clin Immunol; 2019 Jun; 203():23-27. PubMed ID: 30953794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel nonsense gain-of-function
    Kuehn HS; Niemela JE; Sreedhara K; Stoddard JL; Grossman J; Wysocki CA; de la Morena MT; Garofalo M; Inlora J; Snyder MP; Lewis DB; Stratakis CA; Fleisher TA; Rosenzweig SD
    Blood; 2017 Sep; 130(13):1553-1564. PubMed ID: 28778864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Heterozygous Mutation in
    Aird A; Lagos M; Vargas-Hernández A; Posey JE; Coban-Akdemir Z; Jhangiani S; Mace EM; Reyes A; King A; Cavagnaro F; Forbes LR; Chinn IK; Lupski JR; Orange JS; Poli MC
    Front Pediatr; 2019; 7():303. PubMed ID: 31417880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NFKB2 mutation in common variable immunodeficiency and isolated adrenocorticotropic hormone deficiency: A case report and review of literature.
    Shi C; Wang F; Tong A; Zhang XQ; Song HM; Liu ZY; Lyu W; Liu YH; Xia WB
    Medicine (Baltimore); 2016 Oct; 95(40):e5081. PubMed ID: 27749582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [De novo NFκB2 gene mutation associated common variable immunodeficiency].
    Luo MZ; Xu T; Xue XH; Wang YP; Wu PL; Chen XM; Tang XM; Zhao XD; Zhang ZY
    Zhonghua Er Ke Za Zhi; 2018 Aug; 56(8):628-632. PubMed ID: 30078247
    [No Abstract]   [Full Text] [Related]  

  • 10. Fatal Enteroviral Encephalitis in a Patient with Common Variable Immunodeficiency Harbouring a Novel Mutation in NFKB2.
    Slade CA; McLean C; Scerri T; Giang TB; Megaloudis S; Strathmore A; Tempany JC; Nicholls K; D'Arcy C; Bahlo M; Hodgkin PD; Douglass JA; Bryant VL
    J Clin Immunol; 2019 Apr; 39(3):324-335. PubMed ID: 30927119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early B cell developmental impairment with progressive B cell deficiency in NFKB2 mutated CVID disease without autoimmunity.
    Lougaris V; Moratto D; Baronio M; Lorenzini T; Rossi S; Gazzurelli L; Bondioni MP; Plebani A
    Clin Immunol; 2019 Aug; 205():153-155. PubMed ID: 30500415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NFKB2 regulates human Tfh and Tfr pool formation and germinal center potential.
    De Leo P; Gazzurelli L; Baronio M; Montin D; Di Cesare S; Giancotta C; Licciardi F; Cancrini C; Aiuti A; Plebani A; Cicalese MP; Lougaris V; Fousteri G
    Clin Immunol; 2020 Jan; 210():108309. PubMed ID: 31751612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel NFKB2 mutation in early-onset CVID.
    Liu Y; Hanson S; Gurugama P; Jones A; Clark B; Ibrahim MA
    J Clin Immunol; 2014 Aug; 34(6):686-90. PubMed ID: 24888602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel mutation in the Nfkb2 gene generates an NF-kappa B2 "super repressor".
    Tucker E; O'Donnell K; Fuchsberger M; Hilton AA; Metcalf D; Greig K; Sims NA; Quinn JM; Alexander WS; Hilton DJ; Kile BT; Tarlinton DM; Starr R
    J Immunol; 2007 Dec; 179(11):7514-22. PubMed ID: 18025196
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Papoutsopoulou S; Tang J; Elramli AH; Williams JM; Gupta N; Ikuomola FI; Sheibani-Tezerji R; Alam MT; Hernández-Fernaud JR; Caamaño JH; Probert CS; Muller W; Duckworth CA; Pritchard DM
    Am J Physiol Gastrointest Liver Physiol; 2022 Oct; 323(4):G306-G317. PubMed ID: 35916405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in NFKB2 and potential genetic heterogeneity in patients with DAVID syndrome, having variable endocrine and immune deficiencies.
    Brue T; Quentien MH; Khetchoumian K; Bensa M; Capo-Chichi JM; Delemer B; Balsalobre A; Nassif C; Papadimitriou DT; Pagnier A; Hasselmann C; Patry L; Schwartzentruber J; Souchon PF; Takayasu S; Enjalbert A; Van Vliet G; Majewski J; Drouin J; Samuels ME
    BMC Med Genet; 2014 Dec; 15():139. PubMed ID: 25524009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autosomal-dominant B-cell deficiency with alopecia due to a mutation in NFKB2 that results in nonprocessable p100.
    Lee CE; Fulcher DA; Whittle B; Chand R; Fewings N; Field M; Andrews D; Goodnow CC; Cook MC
    Blood; 2014 Nov; 124(19):2964-72. PubMed ID: 25237204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opposing roles of Nfkb2 gene products p100 and p52 in the regulation of breast cancer stem cells.
    Yeo SK; French R; Spada F; Clarkson R
    Breast Cancer Res Treat; 2017 Apr; 162(3):465-477. PubMed ID: 28190248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, Immunological, and Genetic Features in Patients with NFKB1 and NFKB2 Mutations: a Systematic Review.
    Fathi N; Nirouei M; Salimian Rizi Z; Fekrvand S; Abolhassani H; Salami F; Ketabforoush AHME; Azizi G; Saghazadeh A; Esmaeili M; Almasi-Hashiani A; Rezaei N
    J Clin Immunol; 2024 Jul; 44(7):160. PubMed ID: 38990428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel NFKB2 mutation in a Chinese patient with DAVID syndrome.
    Xiao B; Fang D; Liu H; Wang L; Qiu W
    Gene; 2019 Mar; 687():319-322. PubMed ID: 30599236
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.